Mara Persano

10PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2026
Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data From the LOR-HCC (Lombardy Real-World HCC Group).

|Mar 23, 2026
The evolving role of futibatinib for advanced cholangiocarcinoma.

Mara Persano, Andrea Casadei-Gardini, Silvia Camera

|Nov 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda

|Sep 06, 2025
Letter Re: Reflections on the MAGIC-D Prognostic Model in Advanced Biliary Tract Cancer.

Mara Persano, Margherita Rimini, Lorenzo Fornaro

|Aug 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.

Monica Niger, Margherita Rimini, Florian Castet

|Jun 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.

Mara Persano, Margherita Rimini, Francesca Salani

Pageof 2

Frequent Collaborators

5 joint publications

Margherita Rimini

3 joint publications

Chiara Pircher

3 joint publications

Florian Castet

2 joint publications

Andrea Casadei-Gardini